Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Subject
Help
Language
English
русский
українська
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Електронний репозитарій ДВНЗ "УжНУ"
Browsing by Author Yevhen Hotko
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 5 of 5
Issue Date
Title
Author(s)
2013
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the PAVES Study
Tamás Pintera
;
Zandra Klippel
;
Alvydas Cesas
;
Adina Croitoru
;
Jochen Decaestecker
;
Peter Gibbs
;
Yevhen Hotko
;
Jacek Jassem
;
Galina Kurteva
;
Jan Novotny
;
Seamus O’Reilly
;
Tomas Salek
;
Maureen Reiner
;
Phuong Khanh Morrow
;
Mi Rim Choi
;
Sadie Whittaker
;
Charles Blanke
2015
Analysis of KRAS/NRAS Mutations in a Phase 3 Study of Panitumumab With FOLFIRI Compared With FOLFIRI Alone as Second-Line Treatment for Metastatic Colorectal Cancer
Marc Peeters
;
Kelly S. Oliner
;
Timothy Jay Price
;
Andres Cervantes
;
Alberto F. Sobrero
;
Michel Ducreux
;
Yevhen Hotko
;
Thierry Andre
;
Emily Chan
;
Florian Lordick
;
Cornelis J. A. Punt
;
Andrew Strickland
;
Gregory Wilson
;
Tudor-Eliade Ciuleanu
;
Laslo Roman
;
Eric Van Cutsem
;
Ying Tian
;
Andre Scott Jung
;
Roger Sidhu
;
Scott D. Patterson
2012
Final results from study 181: Randomized phase III study of FOLFIRI with or without panitumumab (pmab) for the treatment of second-line metastatic colorectal cancer (mCRC)
Alberto F. Sobrero
;
Marc Peeters
;
Timothy Jay Price
;
Yevhen Hotko
;
Andres Cervantes-Ruiperez
;
Michel Ducreux
;
Thierry Andre
;
Emily Chan
;
Florian Lordick
;
Ying Tian
;
Roger Sidhu
2013
Resultsof a phase III, randomized, double-blind, placebocontrolledtrialofpegfilgrastim (PEG) inpatients (pts) receivingfirst-line FOLFOX or FOLFIRI andbevacizumab (B) forcolorectalcancer (CRC)
Tamas Pinter
;
Esteban Abella
;
Alvydas Cesas
;
Adina Croitoru
;
Jochen Decaestecker
;
Peter Gibbs
;
Yevhen Hotko
;
Jacek Jassem
;
Galina Petrova Kurteva
;
Jan Novotny
;
Seamus O'Reilly
;
Tomas Salek
;
May F. Mo
;
L. MiRim Choiand Charles Davic Blanke
2014-05-20
Updated analysis of KRAS/NRAS and BRAF mutations in study 20050181 of panitumumab (pmab) plus FOLFIRI for second-line treatment (tx) of metastatic colorectal cancer (mCRC).
Marc Peeters
;
Kelly Smith Oliner
;
Timothy Jay Price
;
Andres Cervantes
;
Alberto F. Sobrero
;
Michel Ducreux
;
Yevhen Hotko
;
Thierry Andre
;
Emily Chan
;
Florian Lordick
;
Cornelis JA Punt
;
Andrew Strickland
;
Gregory Wilson
;
Tudor E Ciuleanu